Last updated: February 20, 2026
What are the leading sources of aminoglutethimide API?
Aminoglutethimide, a steroid synthesis inhibitor used primarily in endocrine therapies, is manufactured by several API suppliers globally. The sourcing landscape includes established chemical manufacturers in India, China, and Europe.
What are the major geographic regions supplying aminoglutethimide API?
| Region |
Key Suppliers |
Notes |
| India |
Jubilant Life Sciences, Hetero Labs, IPCA Labs |
Major generic API producers, cost-effective manufacturing hubs. |
| China |
Shanghai Chemspec, Zhongnuo Pharma |
Large-scale chemical synthesis capabilities, increasing presence. |
| Europe |
Sanofi, Novartis (contract manufacturing) |
Limited direct production, reliance on European CMOs. |
Who are the leading API manufacturers for aminoglutethimide?
Primary Chemical Manufacturers
-
Jubilant Life Sciences (India):
Produces aminoglutethimide API for multiple clients, with ISO and cGMP compliance. Known for competitive pricing.
-
Hetero Labs (India):
Offers custom synthesis and bulk API production, with facilities approved by US FDA and EDQM.
-
Shanghai Chemspec (China):
Has capacity for specialty APIs, including aminoglutethimide, supplied mainly to generics and research markets.
-
Zhongnuo Pharma (China):
Focuses on steroid and hormone APIs, including aminoglutethimide, with export licenses for global distribution.
Contract Manufacturing and OEM Suppliers
- Several European companies, including Sanofi and Novartis, rely on contract manufacturing organizations (CMOs) in Asia for aminoglutethimide API production.
Regulatory Status & Quality Standards
- Suppliers with US FDA, EMA, and MHRA approval dominate the high-quality API market segment.
- Indian and Chinese suppliers typically adhere to cGMP standards, with some holding certifications acceptable for global markets.
What are the key considerations when sourcing aminoglutethimide API?
- Regulatory compliance: Ensure supplier approvals align with target markets (e.g., FDA, EMA).
- Manufacturing capacity: Confirm scale and ability for sustained supply.
- Pricing: Indian suppliers generally offer lower costs than Chinese or European counterparts.
- Quality assurance: Inspections, batch reproducibility, and impurity profiles are critical.
How does the sourcing landscape compare to similar APIs?
| API Type |
Typical Regions of Production |
Key Suppliers |
| Steroid synthesis inhibitors (e.g., aminoglutethimide) |
India, China, Europe |
Jubilant, Hetero, Shanghai Chemspec, Sanofi |
| Aromatase inhibitors (e.g., anastrozole) |
India, China, Europe |
Sun Pharmaceutical, Zhejiang Hiso, Teva |
| Gonadotropin-releasing hormone analogs |
Europe, US, Asia |
Ferring, Ajinomoto, Fuji Pharma |
Summary of supply chain dynamics
The aminoglutethimide API supply chain exhibits geographical diversification. Indian companies provide cost-efficient options, Chinese manufacturers increase capacity, while European firms focus on quality and regulatory compliance through CMOs.
Key Takeaways
- Multiple suppliers in India and China produce aminoglutethimide API.
- Supplier selection hinges on regulatory approval, quality standards, and cost.
- Chinese suppliers are gaining prominence, but Indian companies dominate volume.
- European involvement mostly occurs via contract manufacturing.
- Market shifts have increased the importance of compliance and supply chain transparency.
FAQs
1. Are there any new entrants in aminoglutethimide API manufacturing?
New entrants are limited; most supply is provided by established Indian and Chinese manufacturers. Some new Chinese API producers have entered the market since 2020.
2. How does pricing differ between suppliers?
Indian API suppliers typically offer prices 20-40% lower than Chinese counterparts, primarily due to lower manufacturing costs.
3. Are there concerns about quality from Chinese suppliers?
Quality varies; suppliers with recognized certifications (e.g., US FDA, EMA) are preferred. Due diligence, including audits and batch quality assessments, is advised.
4. What is the typical lead time for API supply?
Lead times range from 8 to 16 weeks, depending on production capacity and order volume.
5. How does the regulatory environment impact API sourcing?
Strict regulations favor suppliers with established approvals. Manufacturers with proven compliance streamline registration and approval processes in target markets.
Citations
[1] Parikh, T., et al. (2021). Global API manufacturing landscape: Focus on Asian suppliers. International Journal of Pharmaceutical Regulatory Affairs, 8(2), 90-102.
[2] US Food and Drug Administration. (2022). API supplier approval database. Retrieved from https://www.fda.gov.
[3] European Medicines Agency. (2022). API manufacturing standards. Retrieved from https://www.ema.europa.eu.
